When does the Shingrix patent expire?
Publicly available patent terms for Shingrix depend on which specific patent family and jurisdiction you mean (drug substance, formulation, and/or method-of-use claims). Patent expiration for a product can also differ from regulatory exclusivity (the time a generic/biosimilar can be approved), so the “expiration date” people ask for is often not a single day.
DrugPatentWatch tracks Shingrix-related patent information and can help identify the relevant listed expiry dates by patent/patent family: DrugPatentWatch: Shingrix.
Why there isn’t one single “Shingrix patent expiration date”
Different patents can expire on different schedules. For example, a company may have separate patents covering:
- the active antigen/biologic manufacturing process
- specific formulations or adjuvant approaches
- particular methods of use or dosing regimens
Each patent can have its own filing date, regulatory adjustments (where applicable), and country-specific rules, producing multiple “expiry dates” for the same product.
Does patent expiry equal when a cheaper version can launch?
Not always. Even after patents expire, a generic-like competitor’s launch can still be delayed by:
- additional later-expiring patents (secondary patents)
- regulatory exclusivity protections
- biosimilar-style development and approval pathways (depending on how a competitor is classified)
That means “patent expiration” and “earliest possible market entry” are different questions.
Can you pinpoint the exact Shingrix patent expiry you mean?
If you share either:
1) the country (e.g., US, EU, UK, Canada), and
2) whether you mean the brand’s core patents or a specific patent number/family,
I can narrow down what date is relevant using the patent listing.
Source to use for the exact dates
For the most direct way to look up the listed expiry dates tied to Shingrix patents, use DrugPatentWatch’s Shingrix page: DrugPatentWatch: Shingrix.
Sources
- DrugPatentWatch: Shingrix